SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial] (2013)
Fonte: Pharmacogenomics. Unidades: FM, ICB
Assuntos: INSULINA (RESISTÊNCIA), DIABETES MELLITUS, FARMACOLOGIA CLÍNICA, GENES
ABNT
CORRÊA-GIANNELLA, Maria Lucia e MACHADO, Ubiratan Fabres. SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial]. Pharmacogenomics. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.13.45. Acesso em: 19 set. 2024. , 2013APA
Corrêa-Giannella, M. L., & Machado, U. F. (2013). SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial]. Pharmacogenomics. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.2217/pgs.10.93NLM
Corrêa-Giannella ML, Machado UF. SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial] [Internet]. Pharmacogenomics. 2013 ; 14( 8): 847-850.[citado 2024 set. 19 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.13.45Vancouver
Corrêa-Giannella ML, Machado UF. SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial] [Internet]. Pharmacogenomics. 2013 ; 14( 8): 847-850.[citado 2024 set. 19 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.13.45